Halozyme, Inc. (HALO)

Oncology Corporate Profile

Stock Performance

16.8450
0.0650

HQ Location

11388 Sorrento Valley Road
San Diego, CA 92121

Company Description

Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, which increase the dispersion and absorption of biologics, drugs and fluids. Halozyme's pipeline addresses therapeutic areas, including diabetes, oncology and dermatology that have significant unmet medical need.

Website: http://www.halozyme.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
PEGPH20 (+ ABRAXANE® + Gemcitabine)pegylated recombinant human hyaluronidasePancreatic cancerIII
PEGPH20 (+ chemotherapy)pegylated recombinant human hyaluronidasePancreatic cancerII
PEGPH20 (+ eribulin)pegylated recombinant human hyaluronidaseBreast cancerIEisai
PEGPH20 (+ pembrolizumab)pegylated recombinant human hyaluronidaseGastric cancerI
PEGPH20 (+ pembrolizumab)pegylated recombinant human hyaluronidaseNon Small Cell Lung Cancer (NSCLC)I
PEGPH20 (+ atezolizumab)pegylated recombinant human hyaluronidasePancreatic cancerIGenentech

View additional information on product candidates here »

Source: http://www.halozyme.com

Recent News Headlines

8/21/2017 06:20 am

8/21/2017 06:20 am

8/21/2017 06:20 am

8/21/2017 06:20 am

8/16/2017 06:18 pm

8/11/2017 06:18 am

8/11/2017 06:18 am

8/11/2017 06:18 am

8/11/2017 06:18 am

8/11/2017 06:18 am

8/10/2017 12:18 am

8/10/2017 12:18 am

8/10/2017 12:18 am

8/10/2017 12:18 am

8/10/2017 12:18 am

8/8/2017 12:18 pm

8/8/2017 06:18 am

8/4/2017 12:18 pm

8/4/2017 12:18 pm

8/4/2017 12:18 pm

8/4/2017 12:18 pm

8/3/2017 06:19 pm

7/21/2017 06:18 am

7/13/2017 06:18 am

7/10/2017 12:18 pm